2 episodes of surgical debridement during the first month. The lesions began to improve in the second month of medical therapy, when skin grafting was performed. The patient remained well and was discharged after almost 3 months. Medications were continued for a total period of 6 months. The patient has been well for >2 years.
P. insidiosum in tissues resembles agents of zygomycosis morphologically but, unlike the latter, rarely stains with hematoxylin and eosin. Various immunostainings also help identify the organism (4) . With the exception of the facial-cranial form of the disease in the United States (5), most cases in Thailand occur in patients with chronic hemolytic anemia; thalassemia-hemoglobinopathy is the most common underlying disease. Major clinical manifestations include ocular and craniofacial infections in healthy children, arteritis usually originating from lower extremities, and chronic subcutaneous abscesses.
Treatment options reported to be successful include supersaturated potassium iodide for the chronic cutaneous form (2), a combination of terbinafine and itraconazole in a single case of an acute, severe ocular, subcutaneous infection (6) , and therapeutic vaccination for severe infections involving major arteries (7, 8) in conjunction with surgery. The first case suggested that, with chronic pythiosis involving the aorta, effective management is difficult. In the second case, the laboratory was familiar with P. insidiosum isolation procedures; therefore, a quick diagnosis was made and early treatment was instituted. This early form of cutaneous pythiosis is rarely diagnosed properly by most clinical and pathologic laboratories. Human cases probably occur worldwide (9) but are underrecognized and thus, misdiagnosed (5 
Rift Valley Fever Potential, Arabian Peninsula
To the Editor: Rift Valley fever (RVF) virus causes severe disease, abortion, and death in domestic animals (especially young sheep, cattle, and goats) in Africa and the Arabian Peninsula. Humans are infected by mosquitoes, which maintain epizootic transmission, or through exposure to infected animal tissue. Although human disease may be mild, sometimes severe retinitis, meningoencephalitis, or hemorrhagic fever syndromes may develop in patients. In Africa, epizootics and associated human epidemics usually follow heavy rainfall (1) .
RVF was first confirmed outside Africa in September 2000. The outbreak in southwestern coastal Saudi Arabia and neighboring coastal areas of Yemen resulted in an epizootic with >120 human deaths and major losses in livestock populations from disease and slaughter (2, 3) . RVF virus isolated from the floodwater mosquito Aedes vexans arabiensis during the outbreak was closely related to strains from Madagascar (1991) and Kenya (1997), which suggests that the virus was imported through infected mosquitoes or livestock from East Africa (3). The Arabian outbreak followed increased rainfall in nearby highlands that flooded the coastal areas and created ideal environments for mosquito populations similar to those found in RVF-endemic regions of East Africa (4). Most RVF activity was associated with flooded wadi agricultural systems; no cases were reported in the mountains or in dry sandy regions, where surface water does not accumulate long enough to sustain mosquito breeding.
To provide early warning of conditions favorable for RVF epidemics, the National Aeronautics and Space Administration (NASA) and the Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) monitor the satellite-derived normalized difference vegetation index (NDVI), which reflects recent rainfall and other ecologic and climatic factors Since RVF virus can be maintained in mosquito eggs for extended periods and transmitted under favorable conditions (6), the high magnitude of NDVI and rainfall patterns reported should prompt heightened veterinary and human surveillance for RVF in coastal Arabia and mass vaccination of susceptible animals. The current RVF model (7) is indicative of conditions that would promote vector breeding and could result in an outbreak of mosquitoborne diseases.
Screening and Toxigenic Corynebacteria Spread
To the Editor: Diphtheria is rare in countries with high vaccination coverage, but as seen in Europe in recent decades, control can disintegrate rapidly. When diphtheria is rare, surveillance is challenging because clinicians have no experience with the infection, and disease may be mild or atypical in vaccinated persons (1) . Clinicians may give inadequate information to laboratories, and appropriate investigations may not be performed. Identifying cases is facilitated if all throat swabs from patients with pharyngitis are screened by laboratories for corynebacteria, but this procedure is expensive and time consuming. To help balance priorities in diphtheria surveillance, we evaluated the potential benefits of microbiologic screening in preventing secondary spread of toxigenic corynebacteria in England and Wales and estimated the possible consequences of not detecting a case.
The mean number of secondary cases that might occur per index case if screening is not undertaken depends on the mean number of contacts and attack rates, vaccine coverage and efficacy, and duration of protection. Some of these factors are not known precisely, so we estimated them within plausible ranges of values. We varied the number of contacts per case-patient from 2 to 20. Secondary attack rates in susceptible persons are difficult to estimate and distinguish from carriage rates (2), and we varied these from 5% to 50%. Vaccine efficacy in children was varied from 50% to 95%. We estimated the susceptibility of UK adults at 40% (3), vaccination coverage in children at 95% (4), and case-fatality ratio at 6% to 10% (5). For simplicity, the ratio of adults to children among contacts was assumed to be 1:1. We assumed that without specific microbiologic identification of cases, no intervention would take place and that intervention to protect contacts is 100% effective. Such intervention includes early treatment and isolation of cases, chemoprophylaxis, and booster vaccination of contacts. The number of cases that need to be detected to prevent 1 secondary case for different numbers of contacts and attack rates was calculated as the inverse of the number of secondary cases that would result from each case not detected by screening.
The number of cases that must be detected by microbiologic screening to prevent 1 secondary case was most affected by varying the number of contacts per patient and the secondary attack rate (Figure) . If one assumes vaccine efficacy of 95%, an attack rate in susceptible contacts of 5%, and 4 contacts per patient, 1 secondary case is prevented for every 18 cases detected; if attack rates are 30%, then 1 secondary case is prevented for <5 index cases detected. If vaccine efficacy was 50%, the number of cases that would need to be detected to prevent 1 secondary case would fall from 18 to <10 cases for a mean of 4 contacts per case and secondary attack rates of 5%.
For the 53 toxigenic strains of corynebacteria detected in England
